Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Bicarbonate in CRRT
NCT03846258Phase 4Withdrawn
- Sponsor
- Mayo Clinic
- Start
- May 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcium chloride, Prismasate in acute kidney injury (AKI), metabolic acidosis, sponsored by Mayo Clinic. Planned start May 2019; status: withdrawn.
02
Drugs
calcium chloridePrismasate
03
Conditions
acute kidney injury (AKI)metabolic acidosis
Beyond the preview
Go deeper on NCT03846258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846258.